In short. The strongest use in the group, graded honestly: better supported than the rest, and still mixed rather than decisive.
Key points
- Being the strongest use in a group of weakly evidenced treatments is a relative statement.
- It means this is where the evidence is least thin, not that the evidence is strong, and the two are routinely merged in a sentence.
Hair loss is the use where this treatment has the most evidence, and the honest description of that evidence is more interesting than either the marketing or the dismissal.
Why hair has the strongest evidence
Because the outcome is measurable. Hair density and hair count can be assessed in a standardised way, with photography and with counting, which makes a comparison possible in a way that a judgement about facial appearance is not. The studies that exist here mostly concern a common pattern of hair loss, they use repeated sessions over months, and several of them include a comparison group. That is a better evidence base than the skin work, and it exists because the outcome was easier to define.
And it is still mixed
The studies disagree. Some report an improvement in measured hair density compared with a control group, others find little difference, and the measures and the protocols differ enough between them that pooling the results is difficult. The most accurate summary is that there is evidence of an effect in some studies and not in others, on protocols that vary, in populations that differ. That is a real body of work and it is not a settled treatment.
The least weak use is not an established one
Being the strongest use in a group of weakly evidenced treatments is a relative statement. It means this is where the evidence is least thin, not that the evidence is strong, and the two are routinely merged in a sentence.
What the studies do not cover
Whether the effect persists after treatment stops is not well established, and hair loss in most patterns is progressive, so a treatment that has to be repeated indefinitely is a long commitment. How this compares with established medical treatments for hair loss is also not well studied, which is the comparison that would matter most to somebody deciding between them. And the concentration of the preparation is not standardised, so a study of one protocol describes that protocol rather than the treatment as a general proposition.
What follows for a person considering it
That this is a use where the evidence is real and mixed, and that a course of treatment is what has been studied rather than a single session. That the comparison worth asking about is with established medical treatments rather than with doing nothing. And that a progressive condition treated with a repeated procedure is a long-term commitment, so the decision is about whether the commitment is worth it rather than about whether one session helps.
How to weigh a hair study you are shown
- Which pattern of hair loss, and how were participants selected?
- What was measured, with what method, against what comparison group?
- How long did the course run, and what happened after it stopped?
Grading by use and by protocol keeps the strongest finding in the group from being described as though it were a stronger finding than it is.
Frequently asked questions
Is PRP effective for hair loss?
It is the use with the strongest evidence in the group and the evidence is still mixed. More studies exist here than for any other aesthetic use, several with a comparison group, and they disagree. Some report improvement in measures of hair density, others find little difference, and the measures differ between studies.
Which types of hair loss have been studied?
Most of the work concerns a common pattern of hair loss rather than hair loss in general, and the studies differ in how they selected participants. Applying a result from one pattern to another is an assumption, and the pattern matters because the causes differ.
How many sessions are usually needed?
The protocols in the studies involve repeated sessions over months, and the number and interval differ between them. A course rather than a single treatment is what has been studied, which means the commitment is a series of appointments and the evidence describes the series rather than any one session.
Risks & Limitations
- There is no cosmetic approval, and no authority has assessed the claims made for the treatment.
- The platelet concentration depends on the kit, device and spin used, and is not standardised or comparable between clinics.
- Blood handled outside a controlled laboratory is a medium in which bacteria grow, so preparation carries a risk of infection that the source of the blood does not remove.
- The material is reabsorbed over a short period, so it does not restore volume the way a filler does.
- Adding it to another treatment is not evidence that the combination works better than the main treatment alone.
When to Seek Care
- Redness, warmth, swelling or pain that is increasing rather than settling after an injection.
- Discharge from an injection site, or a fever — seek prompt clinical assessment.
- An uneven or lumpy result, or any change in the treated area that concerns you.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — guidance on autologous cellular products and point-of-care preparation
- European Medicines Agency (EMA) and national regulators — guidance on blood-derived and autologous treatments
- National Medical Products Administration (NMPA, China) — regulation of blood-derived preparations and devices
- World Health Organization (WHO) — guidance on the safe preparation and handling of blood components
- Cochrane Library — systematic reviews of platelet-rich plasma for hair loss and skin indications
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.